Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Jan;99(1):91–96. doi: 10.1111/j.1476-5381.1990.tb14659.x

Protective effect of beraprost sodium, a new chemically stable prostacyclin analogue, against the deterioration of baroreceptor reflex following transient global cerebral ischaemia in dogs.

J Kurihara 1, T Sahara 1, H Kato 1
PMCID: PMC1917486  PMID: 2110014

Abstract

1. A possible cerebroprotective effect of a chemically stable prostacyclin analogue, beraprost sodium, was investigated in a canine model of cerebral ischaemia. Cerebral ischaemia was produced by the combined occlusions of the left subclavian and the brachiocephalic arteries with preceding ligations of the intercostal arteries. 2. The decrease in baroreceptor reflex sensitivity (BRS), measured by phenylephrine-induced reflex bradycardia, following 5 min ischaemia was used to assess the cerebroprotective effect. 3. Beraprost (1 microgram kg-1 min-1 i.v., infused for 15 min just before ischaemia) completely prevented the decrease in BRS. Although the lower dose of beraprost (0.1 microgram kg-1 min-1 i.v.) failed to show such a protective effect, its inhibitory effect on ADP-induced platelet aggregation was as potent as that of the higher dose. 4. The extent of decrease in BRS was inversely correlated with the extent of the residual blood flow in the medulla oblongata during ischaemia. Since beraprost did not affect the extent of the residual blood flow during ischaemia, its cerebroprotective effect could not be ascribed to the reduction of the degree of ischaemia by increasing collateral blood flow to the brain. 5. Post-ischaemic reduction of the regional blood flow in the medulla and the cerebral cortex was completely prevented by the higher dose of beraprost. 6. The present study suggests that the cerebroprotective effect of beraprost may be independent of its anti-aggregatory and vasodilator effects. It is possible that the protection may be due to a prostacyclin-like cytoprotective effect through membrane stabilization.

Full text

PDF
91

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiba T., Miyazaki M., Toda N. Vasodilator actions of TRK-100, a new prostaglandin I2 analogue. Br J Pharmacol. 1986 Dec;89(4):703–711. doi: 10.1111/j.1476-5381.1986.tb11174.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Araki H., Lefer A. M. Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol. 1980 Feb;238(2):H176–H181. doi: 10.1152/ajpheart.1980.238.2.H176. [DOI] [PubMed] [Google Scholar]
  3. Bitterman H., Smith B. A., Lefer D. J., Lefer A. M. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock. J Cardiovasc Pharmacol. 1988 Sep;12(3):293–299. doi: 10.1097/00005344-198809000-00006. [DOI] [PubMed] [Google Scholar]
  4. Blackwell G. J., Radomski M., Vargas J. R., Moncada S. Prostacyclin prolongs viability of washed human platelets. Biochim Biophys Acta. 1982 Sep 17;718(1):60–65. doi: 10.1016/0304-4165(82)90009-5. [DOI] [PubMed] [Google Scholar]
  5. Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976 Dec;12(6):897–913. doi: 10.1016/0090-6980(76)90125-8. [DOI] [PubMed] [Google Scholar]
  6. Dougherty J. H., Jr, Levy D. E., Weksler B. B. Experimental cerebral ischemia produces platelet aggregates. Neurology. 1979 Nov;29(11):1460–1465. doi: 10.1212/wnl.29.11.1460. [DOI] [PubMed] [Google Scholar]
  7. Fischer E. G. Impaired perfusion following cerebrovascular stasis. A review. Arch Neurol. 1973 Dec;29(6):361–366. doi: 10.1001/archneur.1973.00490300023002. [DOI] [PubMed] [Google Scholar]
  8. Hallenbeck J. M., Furlow T. W., Jr Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog. Stroke. 1979 Nov-Dec;10(6):629–637. doi: 10.1161/01.str.10.6.629. [DOI] [PubMed] [Google Scholar]
  9. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Joseph R., Welch K. M., Grunfeld S., Oster S. B., D'Andrea G. Baseline and activated platelet cytoplasmic ionized calcium in acute ischemic stroke. Effect of aspirin. Stroke. 1988 Oct;19(10):1234–1238. doi: 10.1161/01.str.19.10.1234. [DOI] [PubMed] [Google Scholar]
  11. Kochanek P. M., Dutka A. J., Kumaroo K. K., Hallenbeck J. M. Effects of prostacyclin, indomethacin, and heparin on cerebral blood flow and platelet adhesion after multifocal ischemia of canine brain. Stroke. 1988 Jun;19(6):693–699. doi: 10.1161/01.str.19.6.693. [DOI] [PubMed] [Google Scholar]
  12. Kurihara J., Nishimura H., Oda N., Kato H. Deterioration of baroreceptor reflex by transient global cerebral ischemia in dogs. Jpn J Pharmacol. 1989 Feb;49(2):255–265. doi: 10.1254/jjp.49.255. [DOI] [PubMed] [Google Scholar]
  13. Kurihara J., Oda N., Kato H. Effect of flunarizine on the attenuation of baroreflex by transient cerebral ischemia. Eur J Pharmacol. 1989 Jun 8;165(1):147–150. doi: 10.1016/0014-2999(89)90781-4. [DOI] [PubMed] [Google Scholar]
  14. Masuda Y., Ochi Y., Ochi Y., Karasawa T., Hatano N., Kadokawa T., Okegawa T. Protective effect of a new prostacyclin analogue OP-2507 against cerebral anoxia and edema in experimental animals. Eur J Pharmacol. 1986 Apr 29;123(3):335–344. doi: 10.1016/0014-2999(86)90706-5. [DOI] [PubMed] [Google Scholar]
  15. Masuda Y., Ochi Y., Ochi Y., Karasawa T., Hatano N., Kadokawa T., Shimizu M. Protective effect of prostaglandins D2, E1 and I2 against cerebral hypoxia/anoxia in mice. Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):282–289. doi: 10.1007/BF00508783. [DOI] [PubMed] [Google Scholar]
  16. Masuda Y., Yasuba M., Zushi K., Ochi Y., Kadokawa T., Okegawa T. Effect of OP-2507, a stable prostacyclin analogue on cerebral ischemia induced by unilateral ligation of common carotid artery in gerbils. Arch Int Pharmacodyn Ther. 1988 Jul-Aug;294:125–136. [PubMed] [Google Scholar]
  17. Nishio S., Matsuura H., Kanai N., Fukatsu Y., Hirano T., Nishikawa N., Kameoka K., Umetsu T. The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species. Jpn J Pharmacol. 1988 May;47(1):1–10. doi: 10.1254/jjp.47.1. [DOI] [PubMed] [Google Scholar]
  18. Obrenovitch T. P., Hallenbeck J. M. Platelet accumulation in regions of low blood flow during the postischemic period. Stroke. 1985 Mar-Apr;16(2):224–234. doi: 10.1161/01.str.16.2.224. [DOI] [PubMed] [Google Scholar]
  19. Ogletree M. L., Lefer A. M., Smith J. B., Nicolaou K. C. Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol. 1979 Jun;56(1-2):95–103. doi: 10.1016/0014-2999(79)90438-2. [DOI] [PubMed] [Google Scholar]
  20. Petito C. K. Platelet thrombi in experimental cerebral infarction. Stroke. 1979 Mar-Apr;10(2):192–196. doi: 10.1161/01.str.10.2.192. [DOI] [PubMed] [Google Scholar]
  21. Pluta R. Influence of prostacyclin on early morphological changes in the rabbit brain after complete 20-min ischemia. J Neurol Sci. 1985 Oct;70(3):305–316. doi: 10.1016/0022-510x(85)90172-8. [DOI] [PubMed] [Google Scholar]
  22. Pluta R. The influence of prostacyclin on the recovery of bioelectric cerebral activity after complete ischemia. Acta Neurol Scand. 1986 Jan;73(1):44–54. doi: 10.1111/j.1600-0404.1986.tb03240.x. [DOI] [PubMed] [Google Scholar]
  23. Schrör K., Ohlendorf R., Darius H. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia. J Pharmacol Exp Ther. 1981 Oct;219(1):243–249. [PubMed] [Google Scholar]
  24. Shah A. B., Beamer N., Coull B. M. Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke. 1985 Jul-Aug;16(4):643–647. doi: 10.1161/01.str.16.4.643. [DOI] [PubMed] [Google Scholar]
  25. Terawaki T., Takakuwa T., Iguchi S., Wakitani K., Kira H., Okegawa T., Kawasaki A., Masuda Y. Effect of a prostacyclin analog OP-2507 on acute ischemic cerebral edema in cats. Eur J Pharmacol. 1988 Jul 26;152(1-2):63–70. doi: 10.1016/0014-2999(88)90836-9. [DOI] [PubMed] [Google Scholar]
  26. Turcáni P., Gotoh F., Ishihara N., Tanaka K., Gomi S., Takashima S., Mihara B. Are blood platelets involved in the pathogenesis of ischemic brain edema in gerbils? Stroke. 1988 Apr;19(4):486–489. doi: 10.1161/01.str.19.4.486. [DOI] [PubMed] [Google Scholar]
  27. Umetsu T., Murata T., Tanaka Y., Osada E., Nishio S. Antithrombotic effect of TRK-100, a novel, stable PGI2 analogue. Jpn J Pharmacol. 1987 Jan;43(1):81–90. doi: 10.1254/jjp.43.81. [DOI] [PubMed] [Google Scholar]
  28. Welsh F. A. Role of vascular factors in regional ischemic injury. Prog Brain Res. 1985;63:19–27. doi: 10.1016/S0079-6123(08)61972-X. [DOI] [PubMed] [Google Scholar]
  29. van den Kerckhoff W., Hossmann K. A., Hossmann V. No effect of prostacyclin on blood flow, regulation of blood flow and blood coagulation following global cerebral ischemia. Stroke. 1983 Sep-Oct;14(5):724–730. doi: 10.1161/01.str.14.5.724. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES